What it's for (Indications)
- This medicine is used to treat Psoriasis (skin disease characterized by red, itchy and scaly patches), Lichen simplex (dry patchy skin), planus eczema (inflammatory disorders causing purplish flat skin bumps), otitis externa (ear inflammation), prurigo (intensely itchy spots), seborrheic dermatitis (skin condition mainly affecting the scalp), contact dermatitis (red, itchy rash due to allergy), steroid-responsive dermatoses of the scalp (skin lesion or defect of the scalp), and severe dandruff.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For topical application, a thin layer of the cream or ointment containing betamethasone valerate, gentamicin, and miconazole should be gently applied to the affected cutaneous area, typically once or twice daily. The precise frequency and duration of treatment are meticulously determined by the prescribing physician, taking into account the severity, extent, and specific nature of the dermatological condition, as well as the patient's individual response. Due to the presence of a potent corticosteroid (betamethasone valerate) and an antibiotic (gentamicin), treatment duration is generally limited to mitigate potential adverse effects such as skin atrophy, striae, telangiectasias, systemic absorption leading to hypothalamic-pituitary-adrenal (HPA) axis suppression, and the development of antimicrobial resistance. Prolonged use, application on large surface areas, use under occlusive dressings, or in intertriginous zones should be approached with extreme caution or entirely avoided without strict medical oversight. Pediatric use, as well as application on the face or highly sensitive skin areas, requires specialized medical supervision and is typically restricted to very short durations. Patients must always adhere strictly to the specific instructions provided by their healthcare professional regarding application technique, frequency, and total treatment period. |
Safety & Warnings
Common Side Effects
- Patients may experience irritation at the application site, redness and dryness, pruritus (severe skin itching), numbness of fingers, skin cracking/tightening, secondary infection, skin atrophy (skin degeneration), malaria, telangiectasia (small, widened blood vessels), cushingoid changes (changes due to excess of cortisol related medicine/agent), adrenal suppression, and allergies.
Serious Warnings
- Black Box Warning: None
- Pregnancy: The effects of this medicine are unknown in pregnant females; therefore, consult a doctor before use.
- Lactation: The effects of this medicine are unknown in nursing females; therefore, consult a doctor before use.
- Precautions: Patients with local irritation at the application site, visual disturbances, and the elderly should be cautious.
- Systemic effects may occur with use over large body areas.
- Prolonged use or application over highly absorptive sites may cause skin atrophy (skin degeneration).
- Do not use for treating diaper dermatoses in infants.
- Avoid prolonged use, and contact with mucous membranes and eye area.
How it Works (Mechanism of Action)
This sophisticated topical combination therapy achieves its comprehensive therapeutic effects through the distinct yet synergistic actions of its three active pharmaceutical ingredients: betamethasone valerate, gentamicin, and miconazole. **Betamethasone valerate**, a potent synthetic fluorinated corticosteroid, exerts its primary functions through robust anti-inflammatory, antipruritic, and vasoconstrictive properties. Its mechanism involves inducing the synthesis of lipocortins (annexins), which are proteins that inhibit phospholipase A2, thereby preventing the release of arachidonic acid—a crucial precursor for the biosynthesis of potent inflammatory mediators such as prostaglandins and leukotrienes. This ultimately reduces capillary permeability and leukocyte migration. **Gentamicin**, an aminoglycoside antibiotic, provides broad-spectrum bactericidal activity by irreversibly binding to the 30S ribosomal subunit of susceptible bacteria. This binding disrupts bacterial protein synthesis, leading to the formation of aberrant proteins, increased bacterial cell membrane permeability, and ultimately, bacterial cell death. It is highly effective against a wide range of Gram-negative bacteria and several Gram-positive organisms, including certain strains of Staphylococcus aureus. **Miconazole**, an imidazole antifungal agent, primarily inhibits the biosynthesis of ergosterol, an essential component of the fungal cell membrane. By impairing ergosterol synthesis, miconazole causes structural and functional damage to the fungal cell membrane, leading to increased permeability, leakage of vital cellular contents, and eventual fungal cell death. Miconazole also exhibits some degree of antibacterial activity against certain Gram-positive bacteria. The combined action of these agents effectively targets the inflammatory, bacterial, and fungal components commonly found in mixed dermatological conditions.
Commercial Brands (Alternatives)
No other brands found for this formula.